Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the global burden of disease study 2019

References

• UNAIDS. AIDS BY THE NUMBERS 2021; [cited 2021 Sep 1]. Available from: https://www.unaids.org/en.
   Google Scholar
• WHO. Global tuberculosis report 2020. Geneva, Switzerland: WHO; 2020.
   Google Scholar
• GBD 2019. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871.
   PubMed Web of Science ®Google Scholar
• Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24(2):351–376.
   PubMed Web of Science ®Google Scholar
• Bisson GP, Bastos M, Campbell JR, et al. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data Meta-analysis. Lancet. 2020;396(10248):402–411.
   PubMed Web of Science ®Google Scholar
• Ford N, Shubber Z, Meintjes G, et al. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV. 2015;2(10):e438–e444.
   PubMed Web of Science ®Google Scholar
• Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018;16(2):80–90.
   PubMed Web of Science ®Google Scholar
• Marcy O, Tejiokem M, Msellati P, et al. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018;5(2):e87–e95.
   PubMed Web of Science ®Google Scholar
• Sultana ZZ, Hoque FU, Beyene J, et al. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):51–51.
   PubMed Web of Science ®Google Scholar
• Pietersen E, Ignatius E, Streicher EM, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet. 2014;383(9924):1230–1239.
   PubMed Web of Science ®Google Scholar
• GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990–2016: results from the global burden of diseases, injuries, and risk factors 2016 study. Lancet Infect Dis. 2018;18(12):1329–1349.
   PubMed Web of Science ®Google Scholar
• Podlekareva DN, Efsen AM, Schultze A, et al. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Lancet HIV. 2016;3(3):e120–e131.
   PubMed Web of Science ®Google Scholar
• UNAIDS. 2020 Global AIDS report seizing the moment: tackling entrenched inequalities to end epidemics. Geneva, Switzerland: UNAIDS; 2020.
   Google Scholar
• Rabie H, Frigati L, Hesseling AC, et al. Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children. J Int AIDS Soc. 2015;18(Suppl 6):20236.
   PubMedGoogle Scholar
• Floyd K, Glaziou P, Houben R, et al. Global tuberculosis targets and milestones set for 2016-2035: definition and rationale. Int J Tuberc Lung Dis. 2018;22(7):723–730.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Mekonnen D, Shiferaw AM, et al. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in North-east Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961.
   PubMed Web of Science ®Google Scholar
• Maimaiti R, Zhang Y, Pan K, et al. High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China. BMC Infect Dis. 2017;17(1):15.
   PubMedGoogle Scholar
• Beshir MT, Beyene AH, Tlaye KG, et al. Incidence and predictors of tuberculosis among HIV-positive children at adama referral hospital and medical college, Oromia, Ethiopia: a retrospective follow-up study. Epidemiol Health. 2019;41:e2019028.
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. [Cited 2021 Jan 17]. Available from: http://ghdx.healthdata.org/gbd-results-tool.
   Google Scholar
• Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Socio-Demographic Index (SDI) 1950–2019 Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME)2020. [Cited 2021 Mar 21]. Available from: http://ghdx.healthdata.org/record/ihme-data/gbd-2019-socio-demographic-index-sdi-1950-2019.
   Google Scholar
• Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063–2066.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–683.
   PubMed Web of Science ®Google Scholar
• WHO. Interim policy on collaborative HIV-TB activities. Geneva, Switzerland: WHO; 2004. Available from: https://www.who.int/tb/publications/tbhiv_interim_policy/en/2020.
   Google Scholar
• Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant tuberculosis and extensively Drug-Resistant tuberculosis. Cold Spring Harb Perspect Med. 2015;5(9):a017863.
   PubMed Web of Science ®Google Scholar
• Lan Z, Ahmad N, Baghaei P, Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017, et al. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2020;8(4):383–394.
   PubMed Web of Science ®Google Scholar
• GBD 2017 HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. Lancet HIV. 2019;6(12):e831–e859.
   PubMed Web of Science ®Google Scholar
• Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–1656.
   PubMed Web of Science ®Google Scholar
• Ghosn J, Taiwo B, Seedat S, et al. HIV. Lancet. 2018;392(10148):685–697.
   PubMed Web of Science ®Google Scholar
• Duarte R, Lönnroth K, Carvalho C, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2018;24(2):115–119.
   PubMed Web of Science ®Google Scholar
• Li N, Manji KP, Spiegelman D, et al. Incident tuberculosis and risk factors among HIV-infected children in Tanzania. AIDS. 2013;27(8):1273–1281.
   PubMed Web of Science ®Google Scholar
• Tobin NH, Aldrovandi GM. Immunology of pediatric HIV infection. Immunol Rev. 2013;254(1):143–169.
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Kay AW, Bacha JM, et al. Tuberculosis among children and adolescents at HIV treatment centers in Sub-Saharan Africa. Emerg Infect Dis. 2020;26(12):2933–2943.
   Web of Science ®Google Scholar
• Ley SD, Harino P, Vanuga K, et al. Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea. BMC Microbiol. 2014;14:307.
   PubMed Web of Science ®Google Scholar
• Kelebi T, Takarinda KC, Commons R, et al. Gaps in tuberculosis care in west sepik province of Papua New Guinea. Public Health Action. 2019;9(1):S68–S72.
   PubMedGoogle Scholar
• Moses I, Main S, Commons RJ, et al. A retrospective study of tuberculosis outcomes in Gulf province, Papua New Guinea. Public Health Action. 2019;9(1):S38–s42.
   PubMedGoogle Scholar
• Sharma A, Hill A, Kurbatova E, Global Preserving Effective TB Treatment Study Investigators, et al. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, russia, and South Africa: a mathematical modelling study. Lancet Infect Dis. 2017;17(7):707–715.
   PubMed Web of Science ®Google Scholar
• WHO. Global status report on alcohol and health. Geneva, Switzerland: WHO; 2018. 450.
   Google Scholar
• Di Gennaro F, Pizzol D, Cebola B, et al. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: a review. Tuberculosis (Edinb). 2017;103:44–51.
   PubMed Web of Science ®Google Scholar
• Miller AC, Nelson AK, Livchits V, Tomsk Tuberculosis Alcohol Working Group, et al. Understanding HIV risk behavior among tuberculosis patients with alcohol use disorders in Tomsk, Russian Federation. PLoS One. 2016;11(2):e0148910–e10.
   PubMed Web of Science ®Google Scholar
• Barr T, Helms C, Grant K, et al. Opposing effects of alcohol on the immune system. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:242–251.
   PubMed Web of Science ®Google Scholar
• Reis RK, Melo ES, Gir E. Factors associated with inconsistent condom use among people living with HIV/aids. Rev Bras Enferm. 2016;69(1):40–46.
   PubMedGoogle Scholar
• Gross R, Bellamy SL, Ratshaa B, et al. Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study. Addiction. 2017;112(1):73–81.
   PubMed Web of Science ®Google Scholar
• Velloza J, Kemp CG, Aunon FM, et al. Alcohol use and antiretroviral therapy non-adherence among adults living with HIV/AIDS in Sub-Saharan Africa: a systematic review and Meta-Analysis. AIDS Behav. 2020;24(6):1727–1742.
   PubMed Web of Science ®Google Scholar
• Francisco J, Oliveira O, Felgueiras Ó, et al. How much is too much alcohol in tuberculosis? Eur Respir J. 2017;49(1):1601468.
   PubMed Web of Science ®Google Scholar
• Molina PE, Happel KI, Zhang P, et al. Focus on: alcohol and the immune system. Alcohol Res Health. 2010;33(1-2):97–108.
   Google Scholar
• Lan C-W, Scott-Sheldon LAJ, Carey KB, et al. Prevalence of alcohol use, sexual risk behavior, and HIV among Russians in high-risk settings: a systematic review and meta-analysis. Int J Behav Med. 2017;24(2):180–190.
   PubMed Web of Science ®Google Scholar
• DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and Central Asia. Curr HIV/AIDS Rep. 2014;11(2):168–176.
   PubMed Web of Science ®Google Scholar
• Post FA, Grint D, Werlinrud AM, et al. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe. J Infect. 2014;68(3):259–263.
   PubMed Web of Science ®Google Scholar
• Beyrer C, Wirtz AL, O'Hara G, et al. The expanding epidemic of HIV-1 in the Russian Federation. PLoS Med. 2017;14(11):e1002462–e62.
   PubMed Web of Science ®Google Scholar
• WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva, Switzerland: WHO; 2016.
   Google Scholar
• Cui Y, Shen H, Wang F, et al. A long-term trend study of tuberculosis incidence in China, India and United States 1992-2017: a joinpoint and age-period-cohort analysis. IJERPH. 2020;17(9):3334.
   Google Scholar
• Davis TEK, Elder MA. HIV knowledge and preferences for HIV prevention among older adults living in the community. Gerontol Geriatr Med. 2020;6:2333721420927948.
   Web of Science ®Google Scholar